1-5 of 5
Paul A. S. Evans
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeted Sequencing Predicts the Development of Myeloid Malignancies and Clinical Outcome in Patients with Unexplained Cytopenia

Catherine Cargo, MB, FRCPath, Kelly Bolton, MD PhD, Tumas Beinortas, MBBS, Paul Glover, MSc, Michael Short, Alexandra Smith, PhD, Jan Taylor, PhD MSc, BSc, Paul A S Evans, PhD, Elli Papaemmanuil, PhD, Simon Crouch, PhD BA, MA, MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 1712.
https://doi.org/10.1182/blood-2019-131402
Published: 2019
Journal Articles

Cdx Report Program: Heterogeneity Revealed in Current Reporting Practices for Hemato-Oncology Companion Diagnostic (CDx) Markers in Multiple Countries

Sabit Delic, PhD, Piers Blombery, MBBS, María José Calasanz, PhD, Devon S. Chabot-Richards, MD, Dolors Colomer, PhD, Matteo G Della Porta, MD, Paul A S Evans, PhD, Torsten Haferlach, MD, Joanne Mason, FRCPath, Jay L Patel, MD, William S. Stevenson, MBBS, PhD, Christian Thiede, MD, Maria Teresa Voso, MD, Jordan Clark
Journal: Blood
Blood (2019) 134 (Supplement_1): 5837.
https://doi.org/10.1182/blood-2019-128652
Published: 2019
Journal Articles

Minimal residual disease is an independent predictor for 10-year survival in CLL

Clinical Trials & Observations Brief Report
Marwan Kwok, Andy C. Rawstron, Abraham Varghese, Paul A. S. Evans, Sheila J. M. O’Connor, Chi Doughty, Darren J. Newton, Paul Moreton, Peter Hillmen
Journal: Blood
Blood (2016) 128 (24): 2770–2773.
https://doi.org/10.1182/blood-2016-05-714162
Published: 2016
Includes: Supplemental data
Journal Articles

Monoclonal B lymphocytes with the characteristics of “indolent” chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts

Andy C. Rawstron, Michael J. Green, Anita Kuzmicki, Ben Kennedy, James A. L. Fenton, Paul A. S. Evans, Sheila J. M. O'Connor, Stephen J. Richards, Gareth J. Morgan, Andrew S. Jack, Peter Hillmen
Journal: Blood
Blood (2002) 100 (2): 635–639.
https://doi.org/10.1182/blood.V100.2.635
Published: 2002
Journal Articles

Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy

Clinical Trials & Observations
Andy C. Rawstron, Ben Kennedy, Paul A. S. Evans, Faith E. Davies, Stephen J. Richards, Andy P. Haynes, Nigel H. Russell, Geoff Hale, Gareth J. Morgan, Andrew S. Jack, Peter Hillmen
Journal: Blood
Blood (2001) 98 (1): 29–35.
https://doi.org/10.1182/blood.V98.1.29
Published: 2001